Gerhard Stadlmayr

Title: Gerhard Stadlmayr: Innovator in Extracellular Vesicle Technology

Introduction

Gerhard Stadlmayr is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of methods related to extracellular vesicles. With a total of 2 patents, his work has the potential to impact various applications in medicine and research.

Latest Patents

Stadlmayr's latest patents include innovative methods for producing target-specific extracellular vesicles. This method involves modifying a polynucleotide that encodes an extravesicular domain of an extracellular vesicle surface protein. By incorporating a target binding site within the extravesicular domain, he has created a repertoire of polynucleotides that can recognize predetermined targets. Another notable patent is for cysteine engineered antigen-binding molecules. This invention features an antigen-binding member that includes a specific antigen-binding moiety and an engineered antibody Fc region, allowing for enhanced binding capabilities.

Career Highlights

Throughout his career, Gerhard Stadlmayr has worked with notable companies such as Evercyte GmbH and Merck Patent GmbH. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Stadlmayr has collaborated with several professionals in his field, including Gordana Wozniak-Knopp and Stefan Vogt. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Gerhard Stadlmayr is a distinguished inventor whose work in extracellular vesicle technology showcases his innovative spirit and dedication to advancing biotechnology. His contributions are poised to make a lasting impact in the scientific community.